355 related articles for article (PubMed ID: 24748565)
1. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery.
Sousa-Uva M; Storey R; Huber K; Falk V; Leite-Moreira AF; Amour J; Al-Attar N; Ascione R; Taggart D; Collet JP;
Eur Heart J; 2014 Jun; 35(23):1510-4. PubMed ID: 24748565
[No Abstract] [Full Text] [Related]
2. Development and clinical use of prasugrel and ticagrelor.
Ahmad S; Storey RF
Curr Pharm Des; 2012; 18(33):5240-60. PubMed ID: 22724412
[TBL] [Abstract][Full Text] [Related]
3. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
Clemmensen P; Dridi NP; Holmvang L
Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983
[TBL] [Abstract][Full Text] [Related]
4. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets.
Scharbert G; Wetzel L; Schrottmaier WC; Kral JB; Weber T; Assinger A
Transfusion; 2015 Jun; 55(6):1320-6. PubMed ID: 25641006
[TBL] [Abstract][Full Text] [Related]
6. "Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient?
Kern MJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):255-62. PubMed ID: 22271555
[No Abstract] [Full Text] [Related]
7. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Aradi D; Komócsi A; Vorobcsuk A; Serebruany VL
Thromb Haemost; 2013 Jan; 109(1):93-101. PubMed ID: 23197191
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications.
Floyd CN; Passacquale G; Ferro A
Clin Pharmacokinet; 2012 Jul; 51(7):429-42. PubMed ID: 22568693
[TBL] [Abstract][Full Text] [Related]
9. Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?
Alber HF; Huber K; Pachinger O; Frick M
Wien Klin Wochenschr; 2011 Aug; 123(15-16):468-76. PubMed ID: 21800048
[TBL] [Abstract][Full Text] [Related]
10. [Novel agents in antiplatelet therapy].
Ağırbaşlı M; Güvenç H; Cinçin A
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):369-78. PubMed ID: 21200111
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment platelet reactivity contribution to residual, post-treatment platelet reactivity in prasugrel-treated and ticagrelor-treated patients.
Alexopoulos D; Xanthopoulou I; Davlouros P; Tsigkas G; Damelou A; Theodoropoulos KC; Gkizas V; Hahalis G
J Thromb Haemost; 2013 Feb; 11(2):381-4. PubMed ID: 23216658
[No Abstract] [Full Text] [Related]
12. Clopidogrel in coronary artery disease: update 2012.
Huber K
Adv Cardiol; 2012; 47():31-8. PubMed ID: 22906901
[TBL] [Abstract][Full Text] [Related]
13. New anti-platelet agents: the end of resistance?
Kastrati A
Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
[TBL] [Abstract][Full Text] [Related]
14. Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist.
Azmoon S; Angiolillo DJ
Catheter Cardiovasc Interv; 2013 Feb; 81(2):232-42. PubMed ID: 22581463
[TBL] [Abstract][Full Text] [Related]
15. [Differentiated antiplatelet therapy for acute coronary syndromes].
Schäfer A; Arntz HR; Boudriot E; Garlichs C; Hoffmann S; Ince H; Klingenheben T; Weil J; Zugck C; Helms TM; Silber S
Dtsch Med Wochenschr; 2014 Jan; 139(4):152-8. PubMed ID: 24430955
[TBL] [Abstract][Full Text] [Related]
16. How to manage prasugrel and ticagrelor in daily practice.
Bonhomme F; Fontana P; Reny JL
Eur J Intern Med; 2014 Mar; 25(3):213-20. PubMed ID: 24529662
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity.
Lhermusier T; Lipinski MJ; Tantry US; Escarcega RO; Baker N; Bliden KP; Magalhaes MA; Ota H; Tian W; Pendyala L; Minha S; Chen F; Torguson R; Gurbel PA; Waksman R
Am J Cardiol; 2015 Mar; 115(6):716-23. PubMed ID: 25728845
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
Trenk D; Stone GW; Gawaz M; Kastrati A; Angiolillo DJ; Müller U; Richardt G; Jakubowski JA; Neumann FJ
J Am Coll Cardiol; 2012 Jun; 59(24):2159-64. PubMed ID: 22520250
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome.
Torngren K; Ohman J; Salmi H; Larsson J; Erlinge D
Cardiology; 2013; 124(4):252-8. PubMed ID: 23594617
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
